The Kann owner says the drug quieted his late-night and stress eating but not his love of big flavor, and argues restaurants should rethink portion size.
Recap by typeshit. Full story at Men's Health.
The EMA's CHMP amended its type 2 diabetes indication, and Italian diabetologists say Italy could be the first European country to offer the once-weekly combo.
26:19
A personal update from TakingWeightOff on life after stopping tirzepatide, three weeks in, and what caught them off guard.
Nyah Phengsitthy reports Lilly is staking out a new battlefront around an unapproved obesity treatment. The full story has the details.
A history of drug advertising, from opium-laced tonics and Radithor to the 1938 law after Elixir Sulfanilamide killed over 100 people. Semaglutide is mostly a hook.
The story looks at how longevity and optimization podcasts hype experimental peptides, and where the claims fall short.
The UCL-led study, mostly on tirzepatide, reported 91.4% of women still on treatment at six months. SheMed, the company running the program, co-authored it.
Loading…